Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Desmin is a muscle-specific, type III intermediate filament protein essential for the structural integrity and function of muscle tissue[1][5][7]. It is encoded by the DES gene and found predominantly in cardiac, skeletal, and smooth muscle cells[1][3][5][7]. Desmin connects the sarcolemma, Z disk, and nuclear envelope, providing a scaffold that links the contractile apparatus to the cell’s nucleus, mitochondria, and other organelles, enabling efficient force transmission and mechanical stability during muscle contraction[1][3][6]. Mutations in the DES gene can cause a range of myopathies and cardiomyopathies, collectively termed “desminopathies”[2][5]. Desmin is not considered a direct therapeutic target (receptor, enzyme, etc.); rather, it serves as a critical structural protein and a diagnostic biomarker in muscle pathology[1][3][5].
Not a direct drug target; pathologies are due to mutations or abnormal assembly rather than targeted pharmacologic modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Desmin (DES).